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The functional regeneration of neuronal processes in the
injured nervous system poses a formidable challenge.
During development, axons - the long processes of neurons -
grow long distances through complex terrains in stereo-
typical patterns to connect with the appropriate targets and
facilitate effective communication. Much energy has been
expended by researchers in investigating how axonal growth
and connectivity are guided and regulated. While a com-
plete understanding is still a long way off, it is clear that
these are complex processes, involving multiple molecular
cues that occur in stereotyped sequences. Many of the cues
mediating axonal growth and guidance are lost in the adult
central nervous system (CNS) and these processes are
further disrupted by injury, resulting in disoriented axons.
The injury itself releases inhibitors of axon growth from
white matter (bundled tracts of axons) [1,2] and local
endogenous glial cells, the supporting non-neuronal cells of
the nervous system, respond to the insult with increased
production of a variety of growth inhibitors [3,4]. In
addition to these environmental changes, there are intrinsic
differences in the growth responses of immature and adult
axons - adult axons grow less strongly. In consequence, it
seems that the key to functional regeneration in the injured
adult spinal cord is the simultaneous modification of
multiple inhibitory cues - a demanding task that requires a
particularly special type of glial cell. In a recent paper in
Journal of Biology, Davies et al. [5] describe the identification
of such cells and their transplantation to promote a
remarkable regeneration of adult axons after spinal cord
transection in the rat.
The cells utilized by Davies et al. [5] are termed GRP-derived
astrocytes. This unusual name derives from the origins of
the cells and reflects recent advances in our understanding
of the cellular development of the CNS. Classical
morphological studies identified the major epochs of neural
development, in which neurons arise before glial cells [6].
Evidence that all major cell types might be derived from
multipotent stem cells emerged from in vitro assays in which
‘neurosphere’-producing cells were isolated, passaged and
shown to generate neurons and the glial cell types astrocytes
and oligodendrocytes [7]. These observations prompted an
intensive search to define intermediate cell types between a
multipotent stem cell and the fully differentiated cellular
products. Using a series of in vitro approaches, Davies et al.
[5] identified precursor cells derived from multipotent stem
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Simultaneous suppression of glial scarring and a general enhancement of axonal outgrowth has
now been accomplished in an adult rat model of spinal cord transection. Transplantation of a
novel astrocyte cell type derived from glial-restricted precursors in vitro raise the eventual
possibility of cellular therapy for spinal cord injury.
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neurons (neuron-restricted precursors, NRPs) or glial cells
(glial-restricted precursors (GRPs) that give rise to astrocytes
and oligodendrocytes) (Figure 1). Treatment of GRPs with a
particular cocktail of growth factors and cytokines results in
a population of cells, the GRP-derived astrocytes, that
express canonical characteristics of astrocytes such as expres-
sion of the intermediate filament protein GFAP (glial
fibrillary acidic protein). These were then used in the
transplant studies. Remarkably, the GRP-derived astrocytes
are far more effective at promoting axonal regeneration than
are their less committed ancestor cells. Recent studies from
other laboratories have used similar approaches to examine
the ability of transplanted neural stem cells [8] or NRPs and
GRPs [9] to promote spinal cord repair. Those analyses
demonstrated the survival, migration and integration of the
transplanted cells into the host tissue, but the characteriza-
tion of axonal regrowth by Davies et al. [5] reveals that these
precursor cell types have a very limited capacity to support
axonal regeneration.
The striking axonal regeneration seen by the authors
following GRP-derived astrocyte transplantation raises the
critical issue of what is special about these cells. It seems
likely that one of the main keys to enhanced axonal re-
generation is modulation of the endogenous host cells’
response to injury rather than the provision of specific
molecular promoters of axonal elongation by the trans-
planted cells. For example, the regeneration-promoting
abilities of GRP-derived astrocytes are not restricted to
particular populations of neurons. Davies et al. [5] severed
the rubrospinal tract - a population of axons that runs from
the brain and is involved in relaying information that
controls muscle function. Animals with injuries to the
rubrospinal tract had lost the ability to coordinate their
fore- and hindlimbs precisely. After transplantation of GRP-
derived astrocytes to the site of the lesion, the team
observed increased regrowth of the rubrospinal tract axons
into the injury site compared with untreated animals, and
enhanced recovery of locomotor function. 
In other experiments the authors found that GRP-derived
astrocytes enhanced the growth of axons from transplants of
sensory dorsal-root ganglion neurons through a lesion.
These axons, which normally derive from neurons located
outside the spinal cord, are likely to use distinct molecular
cues for outgrowth compared with the rubrospinal tract
axons, and it is unlikely that both sets of cues are expressed
at the same time by the GRP-derived astrocytes. Rather, the
GRP-derived astrocytes appear to modulate shared
responses of adult CNS cells to injury, and provide an
environment that recapitulates essential properties of the
developing CNS.
Two aspects seem particularly important. The first is the
suppression of glial scarring that normally accompanies
injury to the CNS. Glial scars result in excessive growth in
size of astrocytes (hypertrophy) and upregulation of the
production of various proteoglycans that inhibit axonal
growth. The onset of the scarring response is significantly
delayed by transplanting GRP-derived astrocytes, which
perhaps allows a window of opportunity for regenerating
axons to traverse the lesion site. Second, transplantation of
GRP-derived astrocytes imposes a striking linear orientation
on host glial cells such that they provide a more uniform
environment through which the regenerating axons grow
more easily.
Davies  et al. [5] provide two main insights that will be
important in approaches to promoting spinal cord repair by
cell transplantation. First, the selection of the appropriate cell
type is critical for regeneration. Cells that are too immature or
uncommitted are relatively ineffective, presumably because
their fate can be dictated by signals at the injury site. Cells
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Figure 1
A model for the sequential generation of distinct cell types in the
vertebrate CNS. Neural stem cells (NSCs) from the rat embryonic
brain give rise to progenitors that are restricted to neuronal or glial
fates. In vitro treatment of glial-derived precursors (GRPs) with
members of the bone morphogenetic protein (BMP) family of secreted
signaling molecules drives their differentiation into a distinct subtype of
astrocyte (type 1 astrocyte, AstI) that promotes repair when
transplanted to the injured adult spinal cord. In contrast, treatment of
GRPs with the secreted protein Sonic hedgehog (Shh), a member of a
different family of signaling molecules, causes their differentiation into
type II astrocytes (AstII) and oligodendrocytes.
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AstIlthat are too mature, as in the host, are relatively ineffective,
presumably because they are programmed to form glial scars.
Thus, the level of commitment or cell differentiation is key.
Second, creation of a ‘regeneration-permissive’ environ-
ment is not neuron-specific. The commonalities of axon
outgrowth seem sufficient for different types of neurons to
be able to benefit from the same treatment. These
observations suggest that axon regeneration is perhaps
fundamentally different from initial axonal pathfinding
during development, which appears to be exquisitely
neuron-specific [10].
This study also raises a number of interesting questions on
the in vivo correlates of GRP-derived astrocytes. For example,
do they represent a distinct cell population in the intact
CNS or are they simply a product of in vitro ‘cell
engineering’? The origin and lineages of glial cells in the
CNS has been extensively studied, particularly in the spinal
cord. Although several models have been proposed linking
neurons and oligodendrocytes in a common lineage
[11,12], more recent studies suggest that this is unlikely
[13,14]. Earlier studies had linked astrocytes and oligo-
dendrocytes in a common lineage [15], and previous work
[16] from two of the authors of Davies et al. [5]
demonstrated a more primitive glial precursor that
generates different types of astrocytes and oligodendrocytes.
The molecular cues used by Davies et al. [5] to generate
GRP-derived astrocytes are operative in the intact CNS but
are likely to be used in concert with multiple other signals
to specify other cell types, including neurons [17-20]. The
origins of astrocytes in vivo remain unclear. Indeed, in other
regions of the CNS astrocytes have been proposed to
represent stem cells on the basis of the expression of GFAP,
and clonal studies in vitro suggest a significant diversity
among spinal cord astrocytes [21]. The precise assessment
of lineage associations between cells of the CNS and
identification of intermediate cell types require novel
approaches and the generation of new molecular markers.
Ultimately, it will be essential to unravel the cellular and
molecular bases of the phenomena described by Davies et
al. [5]. What is it about GRP-derived astrocytes that
facilitates their orientation and what are the molecular
mechanisms by which they promote axonal growth? These
questions will not be answered easily. The model of cell
transplantation into the injured spinal cord is extremely
complex. Multiple cell interactions are occurring simul-
taneously and early interactions are likely to establish
cascades of subsequent events. Such complexity limits the
use of modern DNA array-based discovery approaches, and
insights are more likely to come from cell-based strategies.
The hope is that identification of critical upstream steps in
the regulation of the host glial response to CNS injury that
are modulated by GRP-derived astrocytes might lead to the
identification of key regulators that could be targets for
pharmacological therapeutics.
Regardless of whether there is a precise in vivo counterpart
of the GRP-derived astrocytes and of the molecular
mechanisms by which these cells promote axon elongation,
the studies by Davies et al. [5] reveal both the importance of
cellular maturity in promoting axonal regeneration and
provide a source of cells for effective therapeutic approaches
aimed at adult spinal cord regeneration.
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